April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Novel Mutations in MC1R Gene: First Evidence for OCA Type II Disease in Indian Population
Author Affiliations & Notes
  • Renugadevi Kathirvel
    Department of Genetics, Dr. G.Venkataswamy Eye Research Institute, Aravind Medical Research Foundation-AEH, Madurai, India
  • Sil Asim Kumar
    Netra Niramay Niketan, Vivekananda Mission Asram, Vivenknagar, Chaitanyapur, West Bengal, India
  • Vijayalakshmi Perumalsamy
    Paediatric Clinic, Aravind Eye Care System-AEH, Madurai, Tamil Nadu, India
  • Sundaresan Periasamy
    Department of Genetics, Dr. G.Venkataswamy Eye Research Institute, Aravind Medical Research Foundation-AEH, Madurai, India
  • Footnotes
    Commercial Relationships  Renugadevi Kathirvel, None; Sil Asim Kumar, None; Vijayalakshmi Perumalsamy, None; Sundaresan Periasamy, None
  • Footnotes
    Support  Department of Biotechnology, India
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3299. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Renugadevi Kathirvel, Sil Asim Kumar, Vijayalakshmi Perumalsamy, Sundaresan Periasamy; Novel Mutations in MC1R Gene: First Evidence for OCA Type II Disease in Indian Population. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3299.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Oculocutaneous albinism (OCA) is a heterogeneous group of disorders and shares cutaneous and ocular hypopigmentation associated with common developmental abnormalities of the eye. Mutations in many different loci produce this phenotype. The aim of this study is to screen the MC1R gene mutations in Indian Albinism patients.

Methods: : The peripheral blood samples were collected from eighty genetically unrelated families (and available family members) followed by the diagnosis with standard methods of ophthalmologic views. The genomic DNA samples were screened for OCA type II modifier candidate gene-Melanocortin-1 receptor (MC1R) by bi-direct sequencing reactions.

Results: : Among all the study subjects one novel homozygous missense p.Pro268Arg mutation in MC1R was identified in one of the proband and his affected younger brother. In the same proband two novel heterozygous mutations p.Ile712Arg, p.Arg352Thr and one novel heterozygous synonymous variation p.Gln707Gln in OCA2/P gene were observed. Apart from this one novel heterozygous synonymous SNP p.Ala161Ala in MC1R gene was identified in one of the normal individual from this family. In addition two novel heterozygous mutations p.Val156Met, p.Leu224Phe, one novel polymorphism p.Tyr148Tyr and three reported variations p.Arg163Gln, p.Gln233Gln, p.Thr314Thr were identified in MC1R gene from the study subjects. The novel variations were confirmed by sequencing of 100 control samples.

Conclusions: : This study provides novel informations about the MC1R gene and seems likely to be a disease-causing gene of OCA type II in Indian populations. This is the first report providing genetic evidences for OCA type II disease associated with MC1R gene mutations. This study highlights the need for broader analysis of the involvement of MC1R gene in Indian cohort.

Keywords: genetics • gene modifiers • visual acuity 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×